Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioresorbable vascular scaffolds. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global bioresorbable vascular scaffold market from 2025 to 2032.

Key Insights:

Bioresorbable Vascular Scaffold Market Size (2025E): USD 314.4 Million
Projected Market Value (2032F): USD 592.8 Million
Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Bioresorbable Vascular Scaffold Market - Report Scope:

Bioresorbable vascular scaffolds (BVS) are advanced medical devices used to treat coronary artery disease by providing temporary mechanical support to blood vessels while gradually dissolving in the body. Unlike traditional metallic stents, BVS eliminate the long-term complications associated with permanent implants, such as late stent thrombosis. These scaffolds are primarily utilized in percutaneous coronary intervention (PCI) procedures and are increasingly preferred for younger patients or those requiring future surgical options. The BVS market caters to hospitals, specialty cardiovascular centers, and ambulatory surgical units, offering innovative scaffolds made from polylactic acid (PLA), polycarbonate, and other bioresorbable polymers. Market expansion is driven by a growing burden of cardiovascular diseases, increased demand for next-generation stent technologies, and a shift toward minimally invasive treatment options.

Market Growth Drivers:

The global bioresorbable vascular scaffold market is propelled by several key factors, including the rising prevalence of coronary artery disease, especially in aging and high-risk populations. Increasing patient and physician preference for temporary implants that minimize long-term complications has accelerated the adoption of BVS over traditional stents. Technological advancements, including improved scaffold designs, enhanced drug-eluting properties, and faster degradation rates, are enhancing clinical outcomes and driving product innovation. Furthermore, favorable regulatory approvals in major markets and growing investment in cardiovascular research are supporting market growth. Emerging economies are also witnessing increased adoption due to the rise in healthcare infrastructure and awareness of advanced cardiovascular therapies.

Market Restraints:

Despite its strong growth potential, the bioresorbable vascular scaffold market faces challenges related to high device costs, limited reimbursement policies, and concerns about scaffold strength and long-term efficacy. Initial clinical trials raised safety issues regarding scaffold thrombosis, which impacted early adoption. Regulatory hurdles, including stringent safety evaluations and complex approval pathways, add to market entry challenges for new players. Additionally, physician hesitancy due to the steep learning curve associated with BVS implantation techniques can restrict market expansion, particularly in underdeveloped regions. Addressing these issues through improved training, transparent clinical data, and cost-effective solutions remains essential for broader acceptance.

Market Opportunities:

The bioresorbable vascular scaffold market presents significant opportunities driven by innovations in material science, biodegradable drug delivery systems, and precision-based cardiovascular interventions. The increasing use of advanced imaging and diagnostic tools to support accurate scaffold placement enhances procedural success and patient outcomes. Collaborations between medical device manufacturers and academic institutions are fueling the development of next-generation scaffolds with optimized performance and faster resorption rates. As healthcare systems shift toward value-based care, the potential for reduced long-term complications and repeat procedures positions BVS as a cost-effective solution over time. Expansion into emerging markets and the rising trend of outpatient PCI procedures offer further growth avenues.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the bioresorbable vascular scaffold market globally?
Which materials and technologies are leading innovation in the BVS sector?
How are clinical outcomes and patient safety influencing the adoption of BVS across healthcare systems?
Who are the key players contributing to the bioresorbable vascular scaffold market, and what strategic moves are they making to sustain growth?
What are the emerging trends and long-term prospects in the global BVS market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in R&D to enhance scaffold performance, reduce resorption time, and improve patient outcomes. Strategic partnerships with hospitals, research organizations, and cardiovascular societies facilitate clinical adoption and expand global reach. Additionally, market participants are prioritizing physician education programs, post-marketing surveillance studies, and expansion into high-growth regions to strengthen their market position and drive the transition toward bioresorbable technologies in cardiovascular care.

Key Companies Profiled:

Meril Life Sciences Pvt. Ltd.
Zeus Company LLC
Biotronik
Abbott
MicroPort Scientific Corporation
Kyoto Medical
Elixir Medical (MedImpact Healthcare Systems, Inc.)
Cigna
B. Braun Melsungen AG
Boston Scientific Corporation
REVA Medical

Bioresorbable Vascular Scaffold Market Research Segmentation:

The bioresorbable vascular scaffold market encompasses a variety of materials, technologies, applications, and end-user segments tailored to the evolving needs of cardiovascular intervention.

By Product

Metal Bioresorbable Vascular Scaffold
Polymer Bioresorbable Vascular Scaffold

By Application

Peripheral Artery
Coronary Artery

By End-user

Hospitals
Ambulatory Care Centers
Cardiac Centers
Others

By Region

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

Product Code: PMRREP34715

1. Executive Summary

1.1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-economic Factors
- 2.3.1. The development of biodegradable polymers and next-gen scaffold designs
- 2.3.2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis

4. Price Analysis, 2025A

4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Enterprise Type

5. Global Bioresorbable Vascular Scaffold Market Outlook

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
- 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
  - 5.3.3.1. Metal Bioresorbable Vascular Scaffold
  - 5.3.3.2. Polymer Bioresorbable Vascular Scaffold
- 5.3.4. Market Attractiveness Analysis: Product
5.4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
- 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  - 5.4.3.1. Peripheral Artery
  - 5.4.3.2. Coronary Artery
- 5.4.4. Market Attractiveness Analysis: Application
5.5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
- 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
  - 5.5.3.1. Hospitals
  - 5.5.3.2. Ambulatory Surgical Centers
  - 5.5.3.3. Cardiac Catheterization Labs
  - 5.5.3.4. Others
- 5.5.4. Market Attractiveness Analysis: End-user

6. Global Bioresorbable Vascular Scaffold Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Bioresorbable Vascular Scaffold Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product
- 7.2.3. By Application
- 7.2.4. By End-user
7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 7.4.1.
  - 7.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 7.4.1.2. Polymer Bioresorbable Vascular Scaffold
7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 7.5.1. Peripheral Artery
- 7.5.2. Coronary Artery
7.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Surgical Centers
- 7.6.3. Cardiac Catheterization Labs
- 7.6.4. Others
7.7. Market Attractiveness Analysis

8. Europe Bioresorbable Vascular Scaffold Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product
- 8.2.3. By Application
- 8.2.4. By End-user
8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 8.4.1.
  - 8.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 8.4.1.2. Polymer Bioresorbable Vascular Scaffold
8.5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025-2032
- 8.5.1. Peripheral Artery
- 8.5.2. Coronary Artery
8.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Surgical Centers
- 8.6.3. Cardiac Catheterization Labs
- 8.6.4. Others
8.7. Market Attractiveness Analysis

9. East Asia Bioresorbable Vascular Scaffold Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product
- 9.2.3. By Application
- 9.2.4. By End-user
9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 9.4.1.
  - 9.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 9.4.1.2. Polymer Bioresorbable Vascular Scaffold
9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 9.5.1. Peripheral Artery
- 9.5.2. Coronary Artery
9.6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Surgical Centers
- 9.6.3. Cardiac Catheterization Labs
- 9.6.4. Others
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product
- 10.2.3. By Application
- 10.2.4. By End-user
10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 10.4.1.
  - 10.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 10.4.1.2. Polymer Bioresorbable Vascular Scaffold
10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 10.5.1. Peripheral Artery
- 10.5.2. Coronary Artery
10.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Surgical Centers
- 10.6.3. Cardiac Catheterization Labs
- 10.6.4. Others
10.7. Market Attractiveness Analysis

11. Latin America Bioresorbable Vascular Scaffold Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product
- 11.2.3. By Application
- 11.2.4. By End-user
11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 11.4.1.
  - 11.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 11.4.1.2. Polymer Bioresorbable Vascular Scaffold
11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 11.5.1. Peripheral Artery
- 11.5.2. Coronary Artery
11.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Surgical Centers
- 11.6.3. Cardiac Catheterization Labs
- 11.6.4. Others
11.7. Market Attractiveness Analysis

12. Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook

12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product
- 12.2.3. By Application
- 12.2.4. By End-user
12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
- 12.4.1.
  - 12.4.1.1. Metal Bioresorbable Vascular Scaffold
  - 12.4.1.2. Polymer Bioresorbable Vascular Scaffold
12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 12.5.1. Peripheral Artery
- 12.5.2. Coronary Artery
12.6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Surgical Centers
- 12.6.3. Cardiac Catheterization Labs
- 12.6.4. Others
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2025
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Meril Life Sciences Pvt. Ltd.
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Deployments
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Zeus Company LLC
- 13.3.3. Biotronik
- 13.3.4. Abbott
- 13.3.5. MicroPort Scientific Corporation
- 13.3.6. Kyoto Medical
- 13.3.7. Elixir Medical
- 13.3.8. Cigna
- 13.3.9. B. Braun Melsungen AG
- 13.3.10. Boston Scientific Corporation
- 13.3.11. REVA Medical

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations

Bioresorbable Vascular Scaffold Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032